Main Article Content
Abstract
bladder control due to a brain, spinal cord or nerve problem. This nerve damage can be the result
of diseases such as multiple sclerosis (MS), Parkinson's disease or diabetes. It can also be caused
by infection of the brain or spinal cord, heavy metal poisoning, stroke, spinal cord injury, or
major pelvic surgery. People who are born with problems of the spinal cord, such as spina bifida,
may also have this type of bladder problem. Causes of neurogenic shock is usually a spinal cord
injury. When the nerves in the spinal cord are damaged, they stop sending messagesto the nerves
that control other functions in the body. If nerve signals to the musclesin the blood vessels are
shut down, the vessels stop working properly. Neurogenic bladder affects people with stroke and
Parkinson's disease and many other types of nervous system conditions. Conditions that damage
nerves like advanced diabetes can also cause neurogenic bladder.
Methods:
Study design : Descriptive , Cross -sectional study, , Study patterns : Retrospective study
Place & Time of study : The study took place in Thi Qar governorate , study begun at 2nd of
April 2023 and ended at 6th of May 2023
Study Population : The population of Thi Qar about 2 million , The study included the
students and staff from Thi Qar University, children younger than 18 and elderly above 80 were
excluded.
Analysis :
Qualitative data had been analyzed by using SPSS (statistical package for social science) , were
Reliability , frequency , percentage and chi square had been calculated
Results:
A 55 patients suffer from neurogenic bladder, were recruited in this studythat focus on different
aspects of assessment, that include their socio-demographyclinical character that scored according
to Binned score
Article Details
Copyright (c) 2023 University of Thi-Qar Journal Of Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
- References:-
- Central nervous control of micturition and urine storage. Sugaya K, Nishijima S,
- Miyazato M, Ogawa Y. J Smooth Muscle Res. 2005;41:117–
- [PubMed (https://pubmed.ncbi.nlm.nih.gov/16006745)] [GoogleScholar
- Receptors, channels, and signalling in the urothelial sensory system inthe bladder. Merrill
- L, Gonzalez EJ, Girard BM, Vizzard MA. Nat RevUrol. 2016;13:193–204. [PMC free article
- The striated urogenital sphincter muscle in the female. Oelrich TM. Anat Rec.
- ;205:223–232. [PubMed [Google Scholar
- The urethral sphincter muscle in the male. Oelrich TM. Am J Anat. 1980;158:229–246.
- [PubMed (https://pubmed.ncbi.nlm.nih.gov/7416058)][Google Scholar
- Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C. Mechanismsof disease: The
- epidemiology of bladder cancer. Nat Clin Pract Urol.
- Cumberbatch MG, Rota M, Catto JW, La Vecchia C. The Role of Tobacco Smoke in
- Bladder and Kidney Carcinogenesis: A Comparison ofExposures and Meta-analysis of Incidence
- and Mortality Risks. Eur Urol.
- Thi-Qar Medical Journal (TQMJ):Vol.( 26),No.(2),2023
- Web Site: https://jmed.utq.edu Email: utjmed@utq.edu.iq
- ISSN (Print):1992-9218
- Zeegers MP, Swaen GM, Kant I, Goldbohm RA, van den Brandt PA.Occupational risk
- factors for male bladder cancer: results from a population based case cohort study in the
- Netherlands. Occup EnvironMed.
- Ames BN, Kammen HO, Yamasaki E. Hair dyes are mutagenic: identification of a variety of
- mutagenic ingredients. Proc Natl Acad Sci US A.
- Gaertner RR, Trpeski L, Johnson KC., Canadian Cancer Registries Epidemiology Research
- Group. A case-control study of occupational risk factors for bladder cancer in Canada. Cancer
- Causes Control.
- Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ,
- Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM. Treatment
- of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.
- Stephenson LA, Kolka MA. Acetylcholinesterase inhibitor, pyridostigmine bromide,
- reduces skin blood flow in humans. Am JPhysiol. 1990 April.
- Abern MR, Dude AM, Tsivian M, Coogan CL. The characteristicsof bladder cancer after
- radiotherapy for prostate cancer. Urol Oncol. 2013 November.
- Linn JF, Sesterhenn I, Mostofi FK, Schoenberg M. The molecular characteristics of
- bladder cancer in young patients.
- Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, Hernández V,
- Kaasinen E, Palou J, Rouprêt M, van Rhijn BWG, ShariatSF Soukup V, Sylvester RJ, Zigeuner R.
- EAU Guidelines.
References
References:-
Central nervous control of micturition and urine storage. Sugaya K, Nishijima S,
Miyazato M, Ogawa Y. J Smooth Muscle Res. 2005;41:117–
[PubMed (https://pubmed.ncbi.nlm.nih.gov/16006745)] [GoogleScholar
Receptors, channels, and signalling in the urothelial sensory system inthe bladder. Merrill
L, Gonzalez EJ, Girard BM, Vizzard MA. Nat RevUrol. 2016;13:193–204. [PMC free article
The striated urogenital sphincter muscle in the female. Oelrich TM. Anat Rec.
;205:223–232. [PubMed [Google Scholar
The urethral sphincter muscle in the male. Oelrich TM. Am J Anat. 1980;158:229–246.
[PubMed (https://pubmed.ncbi.nlm.nih.gov/7416058)][Google Scholar
Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C. Mechanismsof disease: The
epidemiology of bladder cancer. Nat Clin Pract Urol.
Cumberbatch MG, Rota M, Catto JW, La Vecchia C. The Role of Tobacco Smoke in
Bladder and Kidney Carcinogenesis: A Comparison ofExposures and Meta-analysis of Incidence
and Mortality Risks. Eur Urol.
Thi-Qar Medical Journal (TQMJ):Vol.( 26),No.(2),2023
Web Site: https://jmed.utq.edu Email: utjmed@utq.edu.iq
ISSN (Print):1992-9218
Zeegers MP, Swaen GM, Kant I, Goldbohm RA, van den Brandt PA.Occupational risk
factors for male bladder cancer: results from a population based case cohort study in the
Netherlands. Occup EnvironMed.
Ames BN, Kammen HO, Yamasaki E. Hair dyes are mutagenic: identification of a variety of
mutagenic ingredients. Proc Natl Acad Sci US A.
Gaertner RR, Trpeski L, Johnson KC., Canadian Cancer Registries Epidemiology Research
Group. A case-control study of occupational risk factors for bladder cancer in Canada. Cancer
Causes Control.
Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ,
Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM. Treatment
of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.
Stephenson LA, Kolka MA. Acetylcholinesterase inhibitor, pyridostigmine bromide,
reduces skin blood flow in humans. Am JPhysiol. 1990 April.
Abern MR, Dude AM, Tsivian M, Coogan CL. The characteristicsof bladder cancer after
radiotherapy for prostate cancer. Urol Oncol. 2013 November.
Linn JF, Sesterhenn I, Mostofi FK, Schoenberg M. The molecular characteristics of
bladder cancer in young patients.
Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, Hernández V,
Kaasinen E, Palou J, Rouprêt M, van Rhijn BWG, ShariatSF Soukup V, Sylvester RJ, Zigeuner R.
EAU Guidelines.
